Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406K Sell
3,810
-398
-9% -$48.2K ﹤0.01% 921
2026
Q1
$688K Buy
4,208
+668
+19% +$103K 0.01% 723
2025
Q4
$616K Buy
3,540
+509
+17% +$92.9K 0.01% 762
2025
Q3
$566K Buy
+3,031
New +$371K 0.01% 714

Other funds holding INSM

NewEdge Wealth's INSM Position: Q2 2026 in Review

NewEdge Wealth reduced its Insmed (INSM) stake by 9.5% in Q2 2026, selling an estimated $48.2K and leaving 3,810 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #921.

NewEdge Wealth first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $688K in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • NewEdge Wealth held 3,810 shares of Insmed worth $406K as of Q2 2026.
  • NewEdge Wealth sold 398 Insmed shares in Q2 2026, an estimated $48.2K.
  • Insmed made up ﹤0.01% of NewEdge Wealth's portfolio in Q2 2026, its #921 holding.
  • NewEdge Wealth first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • NewEdge Wealth's Insmed position peaked at $688K in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.